{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:51:28Z","timestamp":1790373088869,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.clim.2006.03.006","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T07:52:48Z","timestamp":1146210768000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pathogenic human monoclonal antibody against desmoglein 3"],"prefix":"10.1016","volume":"120","author":[{"given":"Shih-Wei","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Cavacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash C.","family":"Bhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Shang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall R.","family":"Posner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Razzaque","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2006.03.006_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00417395","article-title":"Lymphocyte studies in pemphigus","volume":"271","author":"Ahmed","year":"1981","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2006.03.006_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archderm.1980.01640330073017","article-title":"Pemphigus in Hartford County, Connecticut, from 1972\u20131977","volume":"116","author":"Simon","year":"1980","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2006.03.006_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mjd.2003.170","article-title":"Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns","volume":"48","author":"Parlowsky","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1084\/jem.177.2.419","article-title":"Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients","volume":"177","author":"Ahmed","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.03.006_bib6","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1073\/pnas.92.11.5239","article-title":"Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity","volume":"92","author":"Bhol","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2006.03.006_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0896-8411(92)90198-Y","article-title":"Production of a human monoclonal anti-epithelial cell surface antibody derived from a patient with pemphigus vulgaris","volume":"5","author":"Gilbert","year":"1992","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2006.03.006_bib8","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.4049\/jimmunol.163.11.6228","article-title":"BALB\/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3","volume":"163","author":"Fan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.006_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08916930290016655","article-title":"Production of non-pathogenic human monoclonal antibodies to desmoglein 3 from pemphigus vulgaris patient","volume":"35","author":"Bhol","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2006.03.006_bib10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2006.03.006_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.70.1.190","article-title":"Release of infectious Epstein-Barr virus by transformed marmoset leukocytes","volume":"70","author":"Miller","year":"1973","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2006.03.006_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916939008995733","article-title":"The regulation of Epstein Barr Virus transformation of B cells secreting cell surface reactive antibodies","volume":"8","author":"Posner","year":"1990","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2006.03.006_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/hyb.1987.6.611","article-title":"The construction and use of a human\u2013mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies","volume":"6","author":"Posner","year":"1987","journal-title":"Hybridoma"},{"key":"10.1016\/j.clim.2006.03.006_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/088922203322230969","article-title":"Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120","volume":"19","author":"Liu","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.clim.2006.03.006_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/1523-1747.ep12470131","article-title":"Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections","volume":"88","author":"Sabolinski","year":"1987","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-3083.1998.tb00924.x","article-title":"Use of recombinant pemphigus vulgaris antigen in development of ELISA and Ib assays to detect pemphigus vulgaris autoantibodies","volume":"10","author":"Bhol","year":"1998","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2006.03.006_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01112920","article-title":"Immunoblot assay to study the pemphigus vulgaris antigen in normal human epidermis and COLO-16 cell line","volume":"285","author":"Mohimen","year":"1993","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2006.03.006_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1523-1747.ep12337524","article-title":"Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles","volume":"109","author":"Ding","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1523-1747.2002.01743.x","article-title":"A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against desmoglein-1 and desmoglein-3","volume":"118","author":"Arteaga","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib20","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.88.11.5056","article-title":"Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2006.03.006_bib21","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1073\/pnas.87.19.7658","article-title":"Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris","volume":"87","author":"Ahmed","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2006.03.006_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/clim.2000.4972","article-title":"In vitro organ culture model for mucous membrane pemphigoid","volume":"98","author":"Colon","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2006.03.006_bib23","first-page":"379","article-title":"Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin","volume":"42","author":"Kumari","year":"2001","journal-title":"Invest. Opthamol. Visual Sci."},{"key":"10.1016\/j.clim.2006.03.006_bib24","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.4049\/jimmunol.174.6.3454","article-title":"VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7","volume":"174","author":"Weitkamp","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.006_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib27","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.03.006_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2133.1971.tb14190.x","article-title":"Correlation of pemphigoid and pemphigus antibody titres with activity of disease","volume":"84","author":"Sams","year":"1971","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2133.2004.06056.x","article-title":"A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice","volume":"151","author":"Aoki-Ota","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/1523-1747.ep12343081","article-title":"Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients","volume":"106","author":"Amagai","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib31","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2133.2003.05209_10.x","article-title":"Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)","volume":"148","author":"Herrmann","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2006.03.006_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:54:59Z","timestamp":1761494099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661606000842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1521661606000842"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2006.03.006","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic human monoclonal antibody against desmoglein 3","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2006.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}